306
Participants
Start Date
January 1, 2018
Primary Completion Date
August 28, 2022
Study Completion Date
May 28, 2023
Glibenclamide
Glibenclamide is administered with a loading dose of 1.25 mg within 10 hours of stroke onset, orally or through gastric tube, followed by 0.625 mg every 8 hour for 5 days.
Placebo
Placebo is administered with a loading dose of 1.25 mg within 10 hours of stroke onset, orally or through gastric tube, followed by 0.625 mg every 8 hour for 5 days.
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Huadu District People's Hospital of Guangzhou, Guangzhou
Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou
Haikou People's Hospital, Haikou
Nanfang Hospital of Southern Medical University, Guangzhou
Heyuan People's Hospital, Heyuan
Maoming People's Hospital, Maoming
Maoming Traditional Chinese Medical Hospital, Maoming
Nanfang Hospital, Southern Medical University
OTHER